I'm not so pessimistic. The very recent release of the monoclonal antibody Trastuzumab (Herceptin), an expensive medication previously denied to to people with early breast cancers but now made available to them is a case in point. But it wasn't without a struggle and there are I'm sure people in the UK prepared to struggle for these drugs.gibbledygook wrote:... it seems unlikely that anybody using the UK NHS will receive any of the new treatments in the offing because they will all be too expensive according to my neurologist.
Loobie wrote:This makes me just wait with baited breath for the impending state run health care in the US. I can hardly wait........ People in this country will just vote it in and then bitch like mad when they can't get what they want.
I get 80mgx30 lipitor for about $25AUD. Now, technically I should not get it at the subsidised price (as I am taking it off label), and my DR does NOT tick the subsidy box, but all chemists go into autopilot and charge me the subsidised price.mjs wrote:In the UK and Australia, drugs that are subsidised are made available to the entire population for between $3.50 and $35.
.... 'Essential' doesn't mean you have to be on your death bed - it includes the full range of well-established drugs. In the case of MS, that includes Rebif, Avonex, Copaxone and Betaseron.
mjs wrote:Tysabri might not be available yet in the UK or Australia (both being countries that subsidise phama drugs), but I wouldn't swap the situation in Australia or UK with the US for anything.
Users browsing this forum: Cinor